Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Int J Mol Sci ; 24(10)2023 May 19.
Artículo en Inglés | MEDLINE | ID: mdl-37240351

RESUMEN

Neurodegenerative disorders, which are currently incurable diseases of the nervous system, are a constantly growing social concern. They are progressive and lead to gradual degeneration and/or death of nerve cells, resulting in cognitive deterioration or impaired motor functions. New therapies that would ensure better treatment results and contribute to a significant slowdown in the progression of neurodegenerative syndromes are constantly being sought. Vanadium (V), which is an element with a wide range of impacts on the mammalian organism, is at the forefront among the different metals studied for their potential therapeutic use. On the other hand, it is a well-known environmental and occupational pollutant and can exert adverse effects on human health. As a strong pro-oxidant, it can generate oxidative stress involved in neurodegeneration. Although the detrimental effects of vanadium on the CNS are relatively well recognized, the role of this metal in the pathophysiology of various neurological disorders, at realistic exposure levels in humans, is not yet well characterized. Hence, the main goal of this review is to summarize data on the neurological side effects/neurobehavioral alterations in humans, in relation to vanadium exposure, with the focus on the levels of this metal in biological fluids/brain tissues of subjects with some neurodegenerative syndromes. Data collected in the present review indicate that vanadium cannot be excluded as a factor playing a pivotal role in the etiopathogenesis of neurodegenerative illnesses, and point to the need for additional extensive epidemiological studies that will provide more evidence supporting the relationship between vanadium exposure and neurodegeneration in humans. Simultaneously, the reviewed data, clearly showing the environmental impact of vanadium on health, suggest that more attention should be paid to chronic diseases related to vanadium and to the assessment of the dose-response relationship.


Asunto(s)
Contaminantes Ambientales , Enfermedades Neurodegenerativas , Animales , Humanos , Vanadio/toxicidad , Encéfalo , Contaminantes Ambientales/toxicidad , Estrés Oxidativo , Enfermedades Neurodegenerativas/inducido químicamente , Mamíferos
2.
Biology (Basel) ; 12(3)2023 Feb 22.
Artículo en Inglés | MEDLINE | ID: mdl-36979042

RESUMEN

A growing number of reports point to the possible role of environmental factors in determining the age of onset of menopause. Specific metals, such as mercury, cadmium, arsenic and lead can lead to fertility disorders, to endocrine dysregulation, and in addition, their high blood concentrations correlate with the onset of menopause. Changing concentrations of hormones in the blood during this period of a woman's life can also have an impact on SARS-CoV-2 infection, and excessively high or low levels of metals may also be an important predictor for the course of COVID-19. Postmenopausal women are exposed to greater risk of serum biochemical changes, and with the possibility of nutritional disturbances, particularly involving trace minerals, the risk of age-related diseases is very high during this period. These adverse changes in serum trace minerals should be taken into consideration for the early diagnosis and prevention of menopause-related diseases. Dietary supplementation may be necessary, especially where levels are significantly reduced. We performed a manual search of scientific articles cited in major electronic databases (PubMed, EMBASE, Web of Science and Google Scholar) in November 2022 to identify studies relevant to the relationship between metals, COVID-19 and menopause. The effects of metals on the course of menopause is a broad topic and should certainly still be a subject of research, due to, among other things, continuing environmental pollution and the use of metals in many areas of life.

3.
Wiad Lek ; 74(10 pt 1): 2452-2459, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34897003

RESUMEN

OBJECTIVE: The aim: Our work aims to investigate the therapeutic effect of art on children and adolescents with autism spectrum disorder (ASD) up to the age of 18 and to disseminate knowledge about its use as a part of therapy. PATIENTS AND METHODS: Materials and methods: The authors created an anonymous online questionnaire addressed to parents and legal guardians of children and adolescents with and without ASD. The studied population comprised 190 subjects, of which 108 were a control group (children and adolescents without ASD) and 82 - a study group (children and adolescents with ASD). RESULTS: Results: Most respondents did not hear about the therapeutic use of art (59.5%). 20.73% of respondents with ASD participated in therapy using artistic activities. 82.4% participated in music therapy, 23.5% - in theater therapy, and 70.6% - in art therapy. These forms of therapy effectively improved disorders related to social relationships, speech, and atypical behavior. CONCLUSION: Conclusions: There is a positive therapeutic effect of art on children and adolescents with ASD. The therapeutic use of art among the respondents is not very widespread. Artistic activities have a positive impact on social relations, speech, and unusual behavior. Music and visual arts activities seem to positively impact social relationship disorders, while theater activities seem to impact speech disorders positively. Combining several arts in therapy is more beneficial than using just one. Art therapy is most often used at the age of 13 and older.


Asunto(s)
Arteterapia , Trastorno del Espectro Autista , Adolescente , Trastorno del Espectro Autista/terapia , Niño , Humanos , Padres , Habla , Encuestas y Cuestionarios
4.
Vet Q ; 34(4): 185-93, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25330194

RESUMEN

BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) may cause gastrointestinal damage in dogs. HYPOTHESIS/OBJECTIVES: To determine the extent to which lansoprazole, liquorice extract, and a herbal solution exhibit protective effects on colonic mucosa when administered to dogs concurrently with the NSAIDs carprofen or robenacoxib. ANIMALS AND METHODS: Thirty-five healthy beagle dogs (15 male and 20 female) aged 13-14 weeks and weighing 4.3-5.5 kg at the beginning of the experiment were included. Endoscopy and biopsy of the caudal gastrointestinal tract were performed pretreatment and on the last day of a 21-day treatment period with (1) oral carprofen; (2) carprofen and the proton-pump inhibitor lansoprazole; (3) carprofen, liquorice extract, and a herbal solution that contained extracts of thyme, icelandic lichen, hyssop, and saponariae root; (4) robenacoxib; (5) robenacoxib and lansoprazole; (6) robenacoxib, liquorice extract, and herbal solution; or (7) an empty gelatin capsule. Statistical analyses were performed with the Kruskal-Wallis, Cochran's Q, and chi-squared test with p < 0.05 considered significant. RESULTS: Both carprofen and robenacoxib tested damaged the colonic mucosa with most severe microscopic lesions following administration of robenacoxib with lansoprazole. The risk of histopathological lesions in the colon increased most rapidly in robenacoxib with lansoprazole (absolute risk increase -0.85) similar to robenacoxib only (-0.75), whereas the best result was recorded following the plant remedies together with carprofen (-0.15) and the plant remedies together with robenacoxib (-0.2). CONCLUSIONS AND CLINICAL IMPORTANCE: Concurrent administration of liquorice extract and an herbal solution with robenacoxib was associated with decreased severity of the NSAID-induced mucosal lesions.


Asunto(s)
Antiinflamatorios no Esteroideos/toxicidad , Carbazoles/toxicidad , Difenilamina/análogos & derivados , Mucosa Intestinal/efectos de los fármacos , Lansoprazol/uso terapéutico , Fenilacetatos/toxicidad , Extractos Vegetales/uso terapéutico , Inhibidores de la Bomba de Protones/uso terapéutico , Animales , Colon/efectos de los fármacos , Inhibidores de la Ciclooxigenasa 2/toxicidad , Inhibidores de la Ciclooxigenasa/toxicidad , Difenilamina/toxicidad , Perros/metabolismo , Femenino , Glycyrrhiza , Masculino , Polonia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA